氯贝丁酯治疗肾病综合征高脂血症期间的并发症。 - Suppr

Suppr

超能文献

Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia.

作者信息

Bridgman J F, Rosen S M, Thorp J M

出版信息

Lancet. 1972 Sep 9;2(7776):506-9. doi: 10.1016/s0140-6736(72)91905-8.

DOI:10.1016/s0140-6736(72)91905-8

PMID:4115569

Abstract

摘要

相似文献

Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia.

Lancet. 1972 Sep 9;2(7776):506-9. doi: 10.1016/s0140-6736(72)91905-8.

[Treatment of hyperlipemia with clofibrate in a case of nephrotic syndrome: secondary enzymatic and muscular alterations].

J Urol Nephrol (Paris). 1973 Apr-May;79(4):381-3.

Acute muscular syndrome associated with administration of clofibrate.

N Engl J Med. 1968 Oct 17;279(16):856-8. doi: 10.1056/NEJM196810172791604.

[Hypolipemic property and myotoxic action of clofibrate in a case of nephrotic syndrome].

Schweiz Rundsch Med Prax. 1973 Jun 5;62(23):732-7.

[Treatment of primary hyperlipoproteinaemia types, IIa, IIb, 3 and IV with clofibrate (author's transl)].

Dtsch Med Wochenschr. 1973 Dec 7;98(49):2328-33. doi: 10.1055/s-0028-1107251.

Dose-response effect of single and combined clofibrate (Atromidin) and niceritrol (Perycit) treatment on serum lipids and lipoproteins in type II hyperlipoproteinaemia.

Atherosclerosis. 1975 Jul-Aug;22(1):91-101. doi: 10.1016/0021-9150(75)90070-2.

[Primary hyperlipoproteinemia. IV. Treatment].

Pol Arch Med Wewn. 1971 Dec;47(6):589-94.

Comparative study of several hypolipidemic agents related to clofibrate.

Atherosclerosis. 1974 Sep-Oct;20(2):141-53. doi: 10.1016/0021-9150(74)90001-x.

Clofibrate-induced complications in renal disease: a case report.

S Afr Med J. 1977 Nov 5;52(20):806-8.

[Atypical muscular syndrome with myolysis during long-term treatment with fibrates].

Arch Mal Coeur Vaiss. 1988 Jul;81(7):921-3.

引用本文的文献

Hyperlipidemia in childhood nephrotic syndrome.

Pediatr Nephrol. 1993 Oct;7(5):559-66. doi: 10.1007/BF00852550.

Acute renal failure and interstitial nephritis after clofibrate treatment.

Br Med J. 1980 Dec 6;281(6254):1529-30. doi: 10.1136/bmj.281.6254.1529-a.

[Rhabdomyolysis with acute renal failure due to bezafibrate].

Klin Wochenschr. 1981 Apr 15;59(8):413-4. doi: 10.1007/BF01698522.

[Fat and renal failure--therapeutic aspects].

Klin Wochenschr. 1982 Aug;60(15):761-6. doi: 10.1007/BF01721140.

[Bezafibrate-induced myolysis and myoglobinuria in patients with impaired renal function].

Klin Wochenschr. 1984 Apr 16;62(8):346-8. doi: 10.1007/BF01716252.

Alteration of drug-protein binding in renal disease.

Clin Pharmacokinet. 1984 Jan;9 Suppl 1:18-26. doi: 10.2165/00003088-198400091-00003.

Adverse effects of drugs on muscle.

Drugs. 1982 Oct;24(4):304-21. doi: 10.2165/00003495-198224040-00003.

[Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].

Klin Wochenschr. 1982 Apr 1;60(7):327-36. doi: 10.1007/BF01721622.

Binding of certain acidic drugs to human albumin: theoretical and practical estimation of fundamental parameters.

Eur J Clin Pharmacol. 1974 Jul 26;7(4):307-13. doi: 10.1007/BF00560349.

Therapy of lipid disorders.

J Clin Pathol Suppl (Assoc Clin Pathol). 1973;5:72-7. doi: 10.1136/jcp.s1-5.1.72.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验